A prospective, randomized, double blind, placebo controlled, parallel group, multicenter, clinical study to evaluate safety and efficacy of Phlebotroy QPS (heparin sodium topical solution) 1000 IU/ ml in prevention of infusion associated phlebitis.
Phase of Trial: Phase III
Latest Information Update: 16 Jan 2018
At a glance
- Drugs Heparin (Primary)
- Indications Phlebitis
- Focus Therapeutic Use
- Sponsors Troikaa Pharmaceuticals
- 08 Jan 2018 Status changed from not yet recruiting to recruiting.
- 05 May 2017 New trial record